The above information is for your reference only. It cannot be used in place of a consultation with a medical professional nor as a basis of self-diagnosis or for treatment decision. Only your physician can provide you with accurate diagnosis and appropriate treatment.

1. Cho HJ and Kim YJ. Efficacy and safety of oral citicoline in acute ischemic stroke: Drug surveillance study in 4,191 cases. Methods Find Exp Clin Pharmacol 2009;31:171-176.


Product Safety


Somazina  has a favourable safety profile. In a study involving 4,191 patients with acute stroke, no significant safety concerns about Somazina  were identified.  More than 99% of patients experienced no side effects during the study. Only one case, which involved elevated liver enzymes, was related to Somazina  and the levels of liver enzymes of this patient returned to normal 4 days after stopping Somazina   .

® 1